Compare Innovative Industrial Properties Inc (IIPR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Innovative Industrial Properties Inc vs BIO-TECHNE Corp — how do they compare? Innovative Industrial Properties Inc trades at $58.5 (market cap $1.66B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 6.8× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays the higher dividend (13.24%). Which is the better fit depends on your goals.
| IIPR | TECH | |
|---|---|---|
Market Cap | $1.66B | $11.24B |
Sector | Real Estate | Health |
52-Week High | $64.67 | $72.29 |
52-Week Low | $44.58 | $43.31 |
Enterprise Value | $2.20B | $11.32B |
Dividend Yield | 13.24% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IIPR trades at $59.16, up 1.46% on the day, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 revenue of $63.3M and FFO of $1.83 per share, beating estimates (Zacks, August 3, 2026). Financials show a net income margin of 52.27% for 2025, though revenue declined to $266M from $309M in 2024. The balance sheet remains solid with total assets of $2.38B and a low debt-to-asset ratio of 16.58% as of 2025.
Outlook is cautious; analyst consensus is mixed with 36% buy ratings. Key risks include tenant distress impacting cash flow and regulatory uncertainty in the cannabis sector. The stock offers a dividend yield but faces headwinds from declining revenue and high payout ratios. Investment appeal hinges on execution in life sciences and cannabis leasing growth amid competitive pressures.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
